Of the 290 patients at enrollment 16 patients withdrew from the study after the baseline visit for different reasons: lost to follow-up, missing data, withdrawn consent. 148 patients reached an outcome at Follow-up visit 1. Either outcome, target TSH or withdrawal from the study, was reached from the first follow-up visit onward, except for the final visit at week 28, at which point the study was ended, regardless of TSH value.
The mean TSH at the start of the study was 15.8 mIU/L and the median 6.6 mIU/L. Health Care Physicians (HCPs) used the starting dose as per their usual practice, but following the algorithm as trained. The chart above illustrates the wide variation in dosage strengths used as starting dosages. Table 3 illustrates the numbers of patients that left the study at each visit, after an outcome was reached.
After 2 follow-up visits, 65.5 % of the patients reached control. The total control rate in the study was 76.2% (95% CI: 71.0% -80.7%). At study end, 34 (11.7%) of patients experienced over-treatment while 35 (12.1%) of patients still required up-titration to achieve control. The total control rate in the study was 76.2% (95% CI: 71.0% -80.7%). 34 (11.7%) of patients were over-treated at the end of the study. On the other end of the spectrum, 35 (12.1%) of patients still needed to be uptitrated further to achieve control of the TSH value. The variability in dosages used in the study, suggests that there is value in having several strengths of levothyroxine dosages for treating hypothyroidism. The 25 µg and 12.5 µg dosage was used in 54.6% of patients.
The mean thyroxin dosage of 1.12 µg/kg body weight in controlled patients is lower than the recommended 1.6 µg/kg.
The value of treatment algorithms used to assist HCPs with titration of thyroxin dosages in hypothyroidism was confirmed in this study. The study also highlights the need of an initial early follow-up of TSH values (after 7 weeks) and regular monitoring until control is achieved. The total control rate of 76.2% in our study is superior to many important studies cited in this poster. The better outcome may be ascribed to the structured TSH determinations and adherence to the treatment algorithm. This study further highlights that a high proportion (>50%) of patients required the small 25 µg and 12.5 µg dosages for optimal dose titration. Median ( 
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